Monthly Archives: June 2018

DEADLINE ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action Against Molina Healthcare, Inc. (MOH) & Lead Plaintiff Deadline – June 29, 2018

NEW YORK, NY / ACCESSWIRE / June 28, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) and certain of its officers, on behalf of shareholders who purchased or otherwise Molina securities between October 31, 2014 and August 2, 2017, both dates inclusive. Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/moh.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) Molina’s administrative infrastructure was never designed to handle the size and complexity of its rapid growth strategy; and (2) it failed to remediate systemic issues and costly disruptions with critical administrative infrastructure functions, including provider payment and utilization management.

On April 28, 2016, Molina reported that it had missed its earnings targets for the quarter ended March 31, 2016 and sharply cut full-year 2016 earnings guidance, citing higher costs tied to administrative capacity issues. On this news, Molina’s share price fell $12.46, or 19.4%, to close at $51.76 on April 29, 2016. On February 15, 2017, Molina announced its financial and operating results for the quarter and year ended December 31, 2016, advising investors that the Company could not commit to Affordable Care Act (“ACA”) Health Exchange participation beyond 2017. On this news, Molina’s share price fell $10.71, or 17.88%, to close at $49.18 on February 16, 2017. Then, on August 2, 2017, Molina announced its financial and operating results for the quarter ended June 30, 2017, reporting a net loss of $230 million for the quarter, termination of its ACA Health Exchange participation in Utah and Wisconsin, and a major restructuring plan. During the Company’s related earnings call, Molina disclosed to investors that its administrative infrastructure was inadequate to sustain Molina’s rapid growth. On this news, Molina’s share price fell $3.92, or 5.92%, to close at $62.32 on August 3, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/moh or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Molina you have until June 29, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 503509

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ormat Technologies, Inc. (ORA) & Lead Plaintiff Deadline: August 10, 2018

NEW YORK, NY / ACCESSWIRE / June 28, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Ormat Technologies, Inc. (“Ormat” or the “Company”) (NYSE: ORA) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Ormat securities between August 8, 2017 and May 15, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/ora.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) there were errors in the income tax provision primarily relating to Ormat’s valuation allowance based on its ability to utilize foreign tax credits in the U.S. prior to their expiration; (2) Ormat netted certain deferred income tax assets and deferred income tax liabilities across different tax jurisdictions that are not permitted to be netted pursuant to United States generally accepted accounting principles; (3) Ormat’s internal controls over financial reporting were ineffective; (4) Ormat would need to restate its second, third and fourth quarter 2017 financial statements and its full-year 2017 financial statements; and (5) as a result, defendants’ statements about Ormat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times.

On May 11, 2018, Ormat disclosed that the Company was delaying the filing of its Quarterly Report for the period ended March 31, 2018 with the U.S. Securities and Exchange Commission, stating that “management has identified an error in the Company’s financial statement presentation of deferred income tax assets and deferred income tax liabilities that affects the Company’s balance sheets in previous reporting periods.” Ormat further disclosed that “[t]he Company is evaluating the impact of this error on its consolidated financial statements and the extent to which the Company’s annual and quarterly consolidated financial statements filed in previous periods require revision or amendment.” On this news, Ormat’s share price fell $3.58, or over 6%, over two consecutive trading days to close at $52.77 on May 14, 2018.

Then, on May 16, 2018, Ormat announced that the Company “will restate its second, third and fourth quarter 2017 financial statements and its full-year 2017 financial statements,” and stated that “investors should no longer rely upon the Company’s previously issued financial statements for [these] periods . . . , earnings releases for these periods, and other communications relating to these financial statements.” On this news, Ormat’s share price fell $0.67, or 1.26%, to close at $52.35 on May 16, 2018.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/ora or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Ormatyou have until August 10, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 503526

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Switch, Inc. (SWCH) & Lead Plaintiff Deadline: August 10, 2018

NEW YORK, NY / ACCESSWIRE / June 28, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Switch, Inc. (“Switch” or the “Company”) (NYSE: SWCH) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Switch Class A common stock pursuant to and/or traceable to Switch’s Initial Public Offering (“IPO”) commenced on or around October 6, 2017. Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/swch.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933.

The Complaint alleges that Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Switch’s Grand Rapids and Atlanta facilities would never be as profitable as its Las Vegas facility, diminishing the yield on Switch’s recent capital expenditures acquiring and building out those facilities will bear; (2) Switch’s high capital expenditures to create high redundancy levels at its facilities were not as profitable as they once had been in the past; (3) Switch had already spent an additional more than $64 million on unbudgeted capital expenditures during the third quarter of 2017 that was not disclosed to investors until after the IPO; (4) Switch recognized $9.4 million in revenues during FY17 that it would not provide colocation services for until FY18, meaning its reported FY17 revenue growth and its FY18 revenue prospects were both overstated; (5) eBay, Switch’s largest colocation customer, would not be taking possession of colocation space it had reserved at Switch’s Tahoe/Reno facility in early 2018; and (6) as a result of the foregoing, at the time of the IPO, Switch’s business and financial prospects were not what defendants had led the market to believe they were in the Registration Statement.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/swch or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Switch you have until August 10, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 503525

Empire Co. Ltd. Class A to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / June 28, 2018 / Empire Co. Ltd. Class A (OTC PINK: EMLAF) will be discussing their earnings results in their Q4 Earnings Call to be held on June 28, 2018 at 12:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/11249

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 503654

Sleemon Mattress Receives its Endorsement from the World Spine Experts, CDAHK

HONG KONG / ACCESSWIRE / June 28, 2018 / Most conventional mattresses have not transformed noticeably since the 1960s. On the current market, most mattresses are made up of a one size spring system that intertwine in different way to change the firmness of the bed. The original technology was invented in the late 1800s in the seats of horse drawn carriage. Therefore, we are sleeping in beds that are not carries the out-of-date development of the current knowledge of human body and sleep science. As we integrate ergonomics at workstations, car seats, and hone furniture, sleeping on a flat traditional mattress cannot please the current consumers which had made a new trend of ergonomics sleep system. Having reduced the physical stress on the bodies can enhance the sleep quality and well-being.

Dr. Eric Chun-Pu Chu, DC, P (CDAHK Chairman) and Gang Yang (Sleemon CEO)

Sleemon has received its endorsement by the Chiropractic Doctors Association of Hong Kong (CDAHK) for its foam mattress that use specialized designs with ergonomics requirements for clinically sound postural support. They have become publicly listed on the Shanghai Stock Exchange (SSE) in 2012, and controls its entire supply chain, from factory to customer, with 8 registered brands in over 800 retail stores. With over 3,500 employees and facilities totaling more than 460,000 m2, Sleemon’s annual capacity reaches 4 million mattresses, making it one of the world’s largest manufacturers of foam and spring mattresses.

The CDAHK is a professional organization comprised of Hong Kong’s most educated and accomplished chiropractors, representing the healthcare profession in the local government and international community. After thoroughly evaluating Sleemon mattresses, the CDAHK has concluded that their sophisticated line of mattresses is ergonomically balanced and uses chiropractic-sound-design that serve as an important tool for the general health: by alleviating and preventing spinal stress. According to the CDAHK, over 80% of the public have some kind of back pain during their lives, and maintenance of spinal health is crucial of our society.

The evaluation period takes approximately 3 months and the process includes interviews with their management team. After receiving the supporting documents of the proposal, the endorsement committees meet to discuss results and investigate the retail store and visit the manufacture factory. The endorsement consideration was based on the company’s history, credentials, vision, design, innovation and quality control. Upon completion of the examinations, the endorsement committees make its recommendation to the CDAHK executive to grant final approval. Once the executive signs off the final approved, the product endorsement agreement will be signed off that involves terms of yearly endorsement fees.

“The CDAHK is pleased to endorse Sleemon Mattress a health-related benefit for consumers. Our endorsement is granted after thorough review, analysis, testing, discussion, and evaluation by CDAHK’s review committees and final signed by the Executive Committees,” said the CDAHK’s Chairman, Dr. Eric Chun-Pu Chu. “We in development the revolutionized mattress, which will be able to measure patient’s weight, height, sleep pattern, and even heart rate. The CDAHK encourages individuals to choose high-quality mattress as an option to achieve optimum wellness.”

Drs Vincent Chan, Valerie Chu, Gabriel Ng, and Jeffrey Ng were the chiropractors who spend days in factory visits. “Sleemon foam is precision poured for consistency and comfort, digitally cut (convoluted cuts available), fully cured, and lab-tested for quality and low/zero emissions of volatile organic compounds to ensure. They have been selected as the biggest manufacture of IKEA in Asia. It has provided mattresses for world’s leading hotels including Sheraton, Hilton, JW Marriot, Shangri-la. We are happy to see a big change in the mattress industry. It will no longer be old fashion,” Said by Dr Valerie Chu. CDAHK Treasurer.

Unlike a conventional bed, an ergonomics mattress is designed with flexibility in mind – it is designed to support your entire body while you sleep. The results of better quality of sleep, the lesser aches and pains in your body during the day time. With proud enthusiasm, CDAHK endorses the Sleemon mattress as one of our China’s Choice of ergonomics bed.

About the Chiropractic Doctors Association of Hong Kong The Chiropractic Doctors’ Association of Hong Kong (CDAHK) represents the most registered chiropractors in Hong Kong and China. CDAHK has the most educated and accomplished practicing chiropractors, who advance healthcare profession through patient satisfaction and chiropractic principles. We are piloting our profession in the most constructive and patient-centered ways: by collaborating with leaders in the health care professionals, by lobbying for pro-chiropractic legislators, by developing clinical research and using the evidence to support frontline patientcare. We are also the continuing professional development provider for the government. To learn more, visit www.cda.org.hk, connect with us on Facebook, and email at Dr. Eric Chun Pu Chu, chairman@cda.org.hk.

Tel: 852-35947844
Address: GPO Box 2188 Hong Kong

SOURCE: CDAHK

ReleaseID: 504017

Pharmaceutical Excipients Market Worth US$ 8.53 Billion by 2023 – Led by Tablet, Capsule, Topical, Parenteral in “North America and Europe”

Geographically, pharmaceutical excipients market segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Report analyzes various types of pharmaceutical excipients in the market and their adoption patterns.

Pune, India – June 28, 2018 /MarketersMedia/

Pharmaceutical excipients market is expected to reach USD 8.53 billion by 2023 from USD 6.40 billion in 2018, at a CAGR of 5.9%. Overall growth of pharmaceutical excipients market is largely driven by growing pharmaceutical market along with advancements in functional excipients, growing generics market, rapidly growing bio pharmaceuticals sector, emergence of multi functional & co-processed excipients, shifting focus of pharmaceutical manufacturing to emerging markets.

Download Brochure of Pharmaceutical Excipients Market spread across 273 Pages, Profiling 13 Companies and Supported with 190 Tables and 49 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=269819 .

Report analyzes Pharmaceutical Excipients market by product, functionality, type of formulation, & region. Based on product, organic chemical excipients segment accounted for largest share of market in 2017. This can be attributed to use of these excipients in majorly all of pharmaceutical formulations as they offer advantages like increased efficacy in oral delivery of poorly soluble molecules along with increased compressibility and flowability properties.

Key Target Audience:
• Pharmaceutical excipient manufacturers
• Distributors and suppliers of pharmaceutical excipients
• Research and development (R&D) companies
• Drug manufacturers
• Drug suppliers and distributors
• Pharmaceutical/medical associations

The pharmaceutical excipients market is segmented into fillers & diluents, binders, suspending& viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifying agents, and other functionalities. The lubricants & glidants segment is expected to grow at the highest CAGR during the forecast period.

Click Here for More Information on Smart Greenhouse Market with Forecast and Company Profiles at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=269819 .

Study estimates the pharmaceutical excipients market size for 2018 and projects its demand till 2023. Top-down and bottom-up approaches were used to validate size of this market and estimate size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases (such as D&B Hoovers, Bloomberg Business, and Factiva), and annual reports of companies have been used to identify and collect information useful for the study of the market.

Competitive Landscape
1 Overview
2 Market Share Analysis
3 Market Share Analysis: Global
4 Market Share Analysis: North America
5 Market Share Analysis: Europe
6 Market Share Analysis: Asia Pacific
7 Competitive Situation and Trends

Report analyzes various types of pharmaceutical excipients in market & their adoption patterns. It aims at estimating market size & future growth potential of pharmaceutical excipients market for different segments like product, functionality, type of formulations, & region. Report also includes an in-depth competitive analysis of key players in this market along with their company profiles, product offerings, recent developments, and market strategies.

Connect for More Details for Discount and More Information “Pharmaceutical Excipients Market by Type (Organic chemical (Carbohydrate, Petrochemical), Inorganic chemical), Functionality (Filler, Coating, Disintegrant, Binder), Formulation (Tablet, Capsule, Topical, Parenteral) – Global Forecast to 2023” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=269819 .

The report analyzes the various types of pharmaceutical excipients in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the pharmaceutical excipients market for different segments such as product, functionality, type of formulations, and region.

Break of primary participants:
• By Company Type – Tier 1: 45%, Tier 2–33%, and Tier 3–22%
• By Designation – C Level: 43%, Director Level: 38%, and Others: 19%
• By Region – North America: 41%, Europe: 30%, Asia Pacific: 23%, and Rest of the World: 6%

The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.

Contact Info:
Name: Mr. Hrishikesh
Organization: ReportsandReports
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune, Maharashtra, India
Phone: +1 888 391 5441

Source URL: https://marketersmedia.com/pharmaceutical-excipients-market-worth-us-8-53-billion-by-2023-led-by-tablet-capsule-topical-parenteral-in-north-america-and-europe/368270

For more information, please visit http://www.reportsnreports.com/reports/269819-pharmaceutical-excipients-market-by-products-carbohydrates-oleochemicals-petrochemicals-polymers-microcrystalline-cellulose-sugar-calcium-carbonate-by-functionality-fillers-binders-lubricants-preservatives-global-forecast-to-2018.html

Source: MarketersMedia

Release ID: 368270

MHHC Announces New Strategic Alliance

SEATTLE, WA / ACCESSWIRE / June 28, 2018 / McCusker Holdings Corp (OTC PINK: MHHC), a leading provider of help desk, warranty services and complementary technology, announced the formation of a strategic alliance with Southern California based Cypher Scientific, LLC, an established, leading design engineering company focused on high-end design solutions in several industrial and consumer electronics vertical markets, including medical equipment, display solutions, and specialty embedded computing designs.

MHHC CEO, Frank Hawley reports that, “The principals of the re-organized MHHC group of companies and the founders of Cypher Scientific have enjoyed a long and satisfying relationship in adjacent and related business activities, and events have intersected that now enable us to work together in providing excellence to the entire value stream from concept to design and now extending through end user support under an enhanced single provider paradigm.”

James Wilson, President of Cypher Scientific says, “We have chosen MHHC as our preferred partner for warranty and after sale product support in order to enhance our total value proposition to many of our marque customers who do not have in-house infrastructure to adequately support the products that Cypher Scientific designs. We have several products poised for production release this summer that will now have a complete, embedded warranty and support solution available on a global scale.”

Please submit any Investor Relations questions or comments to investors@mccuskerco.com. For more information about McCusker Holdings Corp, please check out the website at www.mccuskerco.com.

Certain statements contained in this email, including statements regarding administrative steps, events, and financial trends that may affect McCusker Holdings Corp’s future operating results, financial position, stock price and cash flows, may constitute forward-looking statements within the meaning of the federal securities laws. These statements are based on our assumptions and estimates and are subject to risks and uncertainties. You can identify these forward-looking statements using words like “strategy,” “expects,” “plans,” “believes,” “will,” “would”, “looks”, “estimates,” “intends,” “feels,” “projects,” “goals,” “targets,” “hopes,” “seeks”, and other words of similar meaning. Pro forma projections of an individual or generic investor’s investment performance always are completely uncertain. Similarly, pro forma projections of splits, electronic share deposits, and timing of initiation of warrant trading, for example, in order to explain the sequence and timing of facilitated share trading and warrant exercise, are always completely uncertain. You can also identify these and other forward statements by the fact that they do not relate strictly to historical or current facts. For these statements, we claim the protection of the safe harbor for forward-looking statements provided by the Private Securities.

SOURCE: McCusker Holdings Corp.

ReleaseID: 503987

Primas and SohoMuse Ensuring Transparency for the Creative Industry

SHANGHAI, CHINA / ACCESSWIRE / June 28, 2018 / Blockchain unites with creative social network in a landmark-collaboration during Primas Press conference on June 24th.

In one of the first collaborations of its kind, Primas will provide the creative social network SohoMuse with a full range of blockchain based services, including the
Decentralized Trusted Content Protocol (DTCP), economic incentives, and decentralized crawlers.

Primas uses blockchain technology to ensure the credibility of content, and uses economic incentives to accelerate the generation and circulation of high-quality content.

SohoMuse has long been exploring blockchain and its potential applications for its members; both companies share a common goal for the security and traceability of content, as well as the protection of intellectual property rights. Through this strategic alliance, Primas will enable SohoMuse to bring the highest level of transparency, trustworthiness and safety into their platform, as well as various aspects of the creative industry.

Kitty Lan, Co-founder of Primas, and Consuelo Vanderbilt Costin, Co-founder of SohoMuse announced the deal together during the ceremony in Shanghai.

Designed for creative professionals, SohoMuse is equal parts community and portfolio platform. The visually rich vertical social network is an online space where Creatives from all fields can showcase their work, network and collaborate with other members in the SohoMuse community, and source the best talent for their projects from virtually anywhere around the world. In the Creative Industry, transparency is essential, and the relationships between creators and agents, managers, producers, and media outlets are based on transparency and trust.

Primas will use the DTCP to retain and format metadata for each individual Creative on SohoMuse by generating a unique DNA. Regardless of how content is spread across the internet, it will always be linked to the original Creative. Metadata is extracted from all kinds of information and links between them are created. The metadata and links are then recorded on the blockchain to make them immutable and traceable. By adding another dimension of data to all the online content, the DTCP makes the content itself more trustworthy and usable. Primas provides a user credibility system to better protect and distribute content, this also makes the tracing of works on the Internet a much easier task.

SohoMuse co-founder Consuelo Vanderbilt Costin said, “SohoMuse and Primas have incredible
synergy as well as a shared vision for the future of distributing content. Our goal has always been for our members to work more efficiently and network more effectively, all within a secure and trusted ecosystem of fellow professionals.”

Kitty Lan, Co-founder of Primas added, “Primas and SohoMuse will work together to make the Internet a more reliable and transparent place for Creatives in the global Creative Industry.”

Within this strategic partnership, Primas and SohoMuse are already looking for more ways to collaborate in the future. Primas will assist SohoMuse in expanding into Asian markets such as China, Japan and South Korea. SohoMuse will in turn enable Primas to expand their presence amongst a broader audience within the content industry, especially in the U.S.

SOURCE: Primas and SohoMuse

ReleaseID: 503839

Novagold Resources Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / June 28, 2018 / Novagold Resources Inc (NYSE: NG) will be discussing their earnings results in their Q2 Earnings Call to be held on June 28, 2018 at 11:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/376

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 503650

Software Motor Company Hires HVAC and Controls Industry Veteran as EVP of Sales Paul Wickberg Brings 30 Years Of Experience In Energy Management And Facility Control Systems To The Company Behind The LED Of Motors

SUNNYDALE, CA / ACCESSWIRE / June 28, 2018 / Software Motor Company (SMC) announced today that it hired HVAC industry veteran Paul Wickberg as Executive Vice President of Sales.

Mr. Wickberg brings than 30 years of energy efficiency, renewable energy and sustainability experience to SMC as it revolutionizes the electric motor industry with a Smart Switched Reluctance Motor that delivers energy savings of 20% to 50% compared to NEMA Premium Efficiency motors.

“Paul leading SMC sales is key to disrupting the $100 billion electric motor market and executing our vision of upgrading every inefficient analog motor with an SMC Smart Motor,” said Ryan Morris, the company’s Executive Chairman. “The market opportunity for our software-controlled super-premium motors is huge. Paul’s executive experience, industry knowledge and network, and reputation for building successful sales teams will help us meet customers’ needs for energy efficiency, reliability and accountability. He’s an outstanding addition to our team.”

Before SMC, Mr. Wickberg was President of National Account Sales at Cylon Retail Solutions, which provides energy management solutions for multi-site retailers. Prior to that, he was President, North America for American Auto-Matrix, a commercial building controls and automation company and subsidiary of Cylon, where he served as a Director. He was Chief Operating Officer and a founding member of Verisae, a software-as-a-service business specializing in web-based asset management, work order process, and energy analytics for multi-site retailers. He was co-founder and President of Computer Process Controls, Inc., now part of Emerson Climate Technologies, which became the largest supplier of food retail energy management systems in North America.

“In my 30-year career, I have never been this excited to join a company. SMC has done what no other company has since the electric motor was invented 100-plus years ago. It used the computing technologies in mobile phones and EVs and a streamlined switched reluctance motor design to invent a software-driven motor that is efficient, reliable and intelligent,” said Wickberg. “SMC is poised for tremendous growth. I look forward to leading sales and serving customers with exceptional products that save energy, cut bottom line costs and operate more sustainably.”

Mr. Wickberg holds a Bachelor of Science in Mechanical Engineering degree from Purdue University.

SMC was founded in Silicon Valley in 2014. It launched this January at the AHR Expo by announcing its Series A of $13,141,592 raised last fall. SMC currently sells smart motors between 1/2HP to 5HP and is scheduled to introduce up to 15HP motors in August.

The company’s Smart Motor Systems are cloud-based, networked, fully programmable from any connected device, and capable of maintaining optimal efficiency across a wide range of operating speeds and torque loads. Current customers use the motors in their HVAC rooftop units and supermarket refrigeration systems.

Energy CIO Insights recently included SMC as one of this year’s Top 10 Smart Energy Solution Providers and the company has won awards from the National Science Foundation, Wells Fargo’s Innovation Incubator, and the CleanTech Open.

About Software Motor Company

Software Motor Company (SMC) was founded in Silicon Valley to bring intelligence to electric motors, which consume over 45% of global electricity. SMC’s Smart Switched Reluctance Motor (SSRM) combines patented hardware and software control with modern IoT technologies to enable the most efficient, reliable, and intelligent motors on the market. The motors are easy-to-retrofit and integrate with new and legacy HVAC, refrigeration, and pumping systems as well as industrial applications. SMC motors deliver energy savings of 20% to 50% compared to NEMA Premium Efficiency motors while providing full programmability and connectivity. Visit www.softwaremotor.com for more information.

Contact

Lori Sinsley
415-308-6970; lori.sinsley@softwaremotor.com

SOURCE: Software Motor Company

ReleaseID: 503881